Unitaid

TB SPEED: Strengthening paediatric TB services for enhanced early detection

Scaling up access to contemporary diagnostics for tuberculosis (GeneXpert) with a focus on HIV-associated TB, drug-resistant TB and early TB case detection

Open polyvalent platforms for sustainable and quality access to Viral Load in resource limited settings

Creating a Private Sector Market for Quality Assured RDTs in Malaria-Endemic Countries

A randomised trial to compare dolutegravir + pharmaco-enhanced darunavir versus recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first-line therapy

HIV/HCV Drug Affordability Project

Medicines Patent Pool Foundation II

Enabling access to a robust and well-tolerated new-generation first-line antiretroviral treatment in low-income countries

Driving equitable access to fit-for-purpose antigen rapid diagnostic tests for COVID-19

Améliorer l'Identification des Détresses Respiratoires chez l'Enfant

Market entry of an improved solid protease inhibitor-based first-line ARV combination therapy for infants and young children with HIV/AIDS

IPTI+

Accelerating access and integration of innovative point of care (POC) HIV technologies in national diagnostics programs Phase 2b

Paediatric TB Center of Excellence

ACT Scale up initiative

Access to Treatment for People Living with HIV in Middle Income Countries

Paediatric HIV/AIDS Treatment Project

Second-line Adult Anti-retroviral (ARV) treatments  

Market Intervention to accelerate uptake of new vector control tools

Accelerating Patient Access to Optimal Antiretrovials

Integrating PrEP into Comprehensive Services for Adolescent Girls and Young Women

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)

Unitaid Explore

Anticov

Accelerating access to innovative point of care (POC) HIV diagnostics Phase 2a

Preparedness for the Rollout of Effective HIV Prevention among Key Affected Populations in Brazil, Peru and Mexico

Unlocking the Hepatitis C diagnostic and treatment market

Open polyvalent platforms for sustainable access to quality and affordable viral load testing in resource-limited settings – Phase 2

Tools for Integrated Management of Childhood Illness

Accelerating Measurable Progress and Leveraging Investments for PPH impact

Transforming IPT for Optimal Pregnancy (TIPTOP)

E-market place for the procurement of public health commodities

ADVANCING SPATIAL REPELLENTS FOR VECTOR-BORNE DISEASE CONTROL

Catalyzing Paediatric TB Innovations

Innovation in paediatric market access (IPMA)

Malaria market intelligence to evaluate global investments and define sustainable strategic options that ensure access to high quality commodities

Providing Access to Early Infant Diagnosis & Viral Load Monitoring by SAMBA – A POC Nucleic Acid Detection System

Introduction of point-of-care Early Infant Diagnosis in decentralized settings: creating a market for affordable, effective, and equitable HIV testing of exposed infants

A Global Network to Improve Access and Quality of HIV Monitoring Technologies

WHO HTM Enabler Grant

Catalytic Long Lasting Insecticidal Nets (LLIN) initiative

Accelerating demand for HIVST among young people in Western and Southern Africa

UNITAID/PSI HIV Self-Testing Africa (STAR)

WHO TB Enabler

Unitaid support to WHO prequalification of medicines and in vitro diagnostics, and to the WHO collaborative procedure for registration

Dolutegravir in Pregnant HIV Mothers and Neonates

Health for All: Increasing access to HIV, TB and hepatitis C medicines through effective use of TRIPS flexibilities

Expanding the use of TRIPS flexibilities to promote affordable access to medicines

LONG acting pipeline to Establish medicines for malaria, tuberculosis and HCV with Infrastructure for sustainable Transitional capacity

Better Access to Treatment for Paediatric MDR-TB

Increasing Market and Public health outcomes through scaling up Affordable Access models of short Course preventive therapy for TB

Supply Side grant

Accelerating tools to drive tuberculosis detection (DriveDx4TB)

HCV Combination Prevention in PWID and Prisoners Project (HEPC3P)

Catalyse uptake of Under-utilised Tools & Treatment Simplification for HEP C (CUTTS HepC)

Use of TRIPS flexibilities to increase affordability of treatment for HIV and HIV/HCV co-infection in MICs

Rectal Artesunate - RAS

Achieving Catalytic Expansion of SMC Services in the Sahel to Save Lives

Improving Severe Malaria Outcomes by strengthening the market for severe malaria treatment (injectable and intrarectal artesunate) and analyzing market potential for pre-referral treatment

Ensuring access to the HCV treatment revolution for HCV/HIV co-infected patients in low and middle income countries

Preventing patent barriers

Implementation of CD4 and VL testing in decentralized resource-limited settings

FIND: Sustainable Global and National Quality Control for Malaria Rapid Diagnostic Tests (RDT)

(PQ Dx II) WHO Prequalification of Medicines and Diagnostics: Increased access to appropriate, quality-assured diagnostics, medical devices and medicines for the prevention, initiation and treatment of HIV/AIDS, TB and Malaria

(PQ Meds II) WHO Prequalification of Medicines and Diagnostics: Increased access to appropriate, quality-assured diagnostics, medical devices and medicines for prevention, initiation and treatment of HIV/AIDS, TB and Malaria

The Medicines Patent Pool Foundation

WHO HTM Enabler HIV-HCV sub-grant Self-Testing component

Autotest, libre d'accéder à la connaissance de son Statut VIH

Assured Artemisinin Supply System (A2S2)

Manufacture and Validation of Rapid Point of Care CD4 Testing in India

Uptake of a Novel, Disposable CD4 Point-of-Care CD4 Test in Developing Countries

Support to Round 6 of the Global Fund to fight AIDS, TB and Malaria

Facilitate and secure the availability of ARV treatments and their proper administration to people living with HIV/AIDS in five African Countries

UNICEF: PMTCT Nutrition

Supply of  Paediatric (Peds) TB medicines

UNICEF: Acceleration of Prevention of Mother-to-Child Transmission (PMTCT) and Scale up of Linkages to Paediatric HIV Care and Treatment for 2007-2009

UNICEF: PMTCT Expansion (PMTCT II)

Multi-Drug Resistant (MDR)-TB Scale-up and Acceleration of Access Project

MDR TB Acceleration of Access Initiative: Strategic Rotating Stockpile

Malaria Prevention-Long Lasting Insecticide Treated Nets (LLINs)

Cost containment, price reductions and increased access to first-line anti-TB drugs

Operational Studies to Validate and Accelerate Uptake of Point-of-Care CD4 Counters

Additional Support to the Coordinated Procurement Planning (CPP) Initiative

Scaling up access to contemporary TB diagnostics (Buy-down)

Accelerating access to Innovative POC HIV diagnostics

UNICEF, WHO: UNITAID support to Liberia & Burundi for supply of ACTs for 2007

Expand TB - MDR TB Diagnostics, Expanding and accelerating access to diagnostics for patients at risk of multi-drug resistant tuberculosis

Affordable Medicines Facility - Malaria (AMFm)

Adherence Support Coalition to End TB (ASCENT)

Rapid, comprehensive targeted gene sequencing solution for drug-resistant TB diagnosis in LMICs

Preventing deaths from cervical cancer by catalysing the use of optimal screening tests and treatment devices.

Scale Up Cervical Cancer Elimination with Secondary prevention Strategy

Repurposing oral TLD to a long-acting injectible combination HIV medicine using a novel technology

COVID Innovations for all (CIFA)

ACCESS TO COVID-19 TOOLS ACCELERATOR’ (ACT-A)

Vayu Explore

Towards Elimination of Congenital Transmission of Chagas Disease in Latin America

WHO HEALTH EMERGENCIES PROGRAM (WHE- 1)

Accelerating Demand for HIV Self-Testing through a Human Centered Design Challenge Fund and Campaign

Unitaid Explore

Unitaid Explore

Malaria Vaccine Implementation Programme (MVIP) Phase 2

TOWARDS ELIMINATION OF CONGENITAL TRANSMISSION OF CHAGAS DISEASE IN LATIN AMERICA (CUIDA CHAGAS)

WHO HEALTH EMERGENCIES PROGRAM (WHE- 2)

TRANSFORM -Tranexamic acid access for all mothers with bleeding after childbirth

Start taking actionfor TB diagnosis (START 4 All)

Research to expand access to Heat-Stable Carbetocin for the treatment of Postpartum Haemorrhage

Access to COVID-19 Tools Accelerator (“ACT-A”)

Research to expand access to Heat-Stable Carbetocin for the treatment of Postpartum Haemorrhage

mRNA Project

Innovate, Involve, Inspire: Preventing Hepatitis C through Community-led Harm Reduction (HEPC III)

Expand New Drugs for TB (endTB)

Medicines Patent Pool Foundation III

VivAction

WHO Malaria Enabler Grant

RTS,S/AS01 Pilot Implementation Programme

Research to expand access to Heat-Stable Carbetocin for the treatment of Postpartum Haemorrhage

Enabling Access – Medical Innovations For All

Mobilizing for Equitable Access, IP-TRIPS

Safer, More Robust and Less Expensive Antiretroviral First-Line Therapy (ADVANCE Trial)

Long-acting injectable formulation of ivermectin as a new vector control tool to reduce malaria transmission (IMPACT)